Leadership & Pay ·
Longeveron, Inc. issued special equity awards to its Executive Chairman on July 6, 2026, consisting of 500,000…
LGVNLongeveron Inc.
Longeveron, Inc. issued special equity awards to its Executive Chairman on July 6, 2026, consisting of 500,000 restricted stock units (RSUs), 100,000 RSUs, and 400,000 non-qualified stock options. The awards, which vest over a three-year period starting October 1, 2026, recognize his role in a March 2026 financing transaction and incentivizeize for continued service. Longeveron, Inc. is a biotechnology company focused on cell therapy.0